Anaphylaxis Associated With Allergen Specific Immunotherapy, Omalizumab, and Dupilumab: A Real World Study Based on the US Food and Drug Administration Adverse Event Reporting System

• Main Authors: Sainan Bian (Author), Pingping Zhang (Author), Lisha Li (Author), Zixi Wang (Author), Le Cui (Author), Yingyang Xu (Author), Kai Guan (Author), Bin Zhao (Author), Zhuanggui Chen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Real-world studies on the allergen specific immunotherapy (AIT), omalizumab, and dupilumab associated anaphylactic events are limited. We aimed to analyze the characteristics of drug associated anaphylaxis, and to compare the differences among different drugs.Methods: A disproportionalit...